Los Angeles, CA, United States of America

Ivan S Krylov


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ivan S. Krylov in Antiviral Drug Development

Introduction: Ivan S. Krylov, a notable inventor based in Los Angeles, CA, has made significant strides in the field of antiviral drug development. With two patents to his name, he has combined his expertise and creativity to enhance the effectiveness of nucleotide analogue drugs. His work not only reflects his innovation but also contributes to the ongoing battle against viral infections.

Latest Patents: Ivan Krylov's latest patents demonstrate his commitment to pioneering new solutions in medicine. One of his notable patents is a "Method to improve antiviral activity of nucleotide analogue drugs," which introduces an amino acid conjugate of a cyclic or acyclic nucleoside phosphonate. This invention showcases a method for preparing an acyclic tyrosine conjugate, which can be vital for enhancing antiviral compounds. Another significant patent, "Tyrosine-based prodrugs of antiviral agents," details a well-researched method of synthesizing tyrosine-based pharmaceutical compounds and their role in inhibiting viral replication.

Career Highlights: Ivan is associated with the University of Southern California, where he leverages his academic background to conduct groundbreaking research. His inventions are a testament to his drive for advancing the field of pharmacology and medicinal chemistry, particularly in the context of treating viral infections.

Collaborations: Throughout his career, Ivan Krylov has collaborated with esteemed colleagues, including Charles E. McKenna and Boris A. Kashemirov. These partnerships further underline the collaborative spirit of research in academic settings, leading to innovations that can significantly impact public health.

Conclusion: Ivan S. Krylov’s contributions to antiviral drug development exemplify the importance of innovation in addressing global health challenges. His patents highlight the potential of combining chemistry and biology to create effective treatments for viral infections. As he continues to work at the University of Southern California, his groundbreaking research and collaborations promise to pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…